Healthcare
NASDAQ companies operating within the Healthcare sector, ranked by market capitalization.
| HSIC | NASDAQ | Henry Schein, Inc. | $84.53 | -0.33% | 1.5M | $9.74B |
| HALO | NASDAQ | Halozyme Therapeutics, Inc. | $81.93 | +1.35% | 1.7M | $9.72B |
| IONS | NASDAQ | Ionis Pharmaceuticals, Inc. | $54.39 | -0.48% | 3.1M | $9.35B |
| ABVX | NASDAQ | Abivax S.A. | $125.70 | -4.16% | 951K | $9.23B |
| BRKR | NASDAQ | Bruker Corporation | $56.69 | -2.64% | 1.2M | $9.2B |
| BRKRP | NASDAQ | Bruker Corporation | $457.63 | +2.78% | 3K | $9.2B |
| NUVL | NASDAQ | Nuvalent, Inc. | $123.96 | 0.00% | 0 | $9.13B |
| KYMR | NASDAQ | Kymera Therapeutics, Inc. | $114.39 | -1.19% | 585K | $9.1B |
| PRAX | NASDAQ | Praxis Precision Medicines, Inc. | $325.30 | +0.90% | 283K | $9.07B |
| SYRE | NASDAQ | Spyre Therapeutics, Inc. | $102.13 | +2.14% | 813K | $8.87B |
| CRNX | NASDAQ | Crinetics Pharmaceuticals, Inc. | $83.65 | -0.08% | 2.3M | $8.86B |
| ALKS | NASDAQ | Alkermes plc | $52.89 | -0.15% | 1.3M | $8.82B |
| PTGX | NASDAQ | Protagonist Therapeutics, Inc. | $136.11 | +0.50% | 298K | $8.75B |
| TGTX | NASDAQ | TG Therapeutics, Inc. | $56.04 | +0.97% | 1.4M | $8.58B |
| APGE | NASDAQ | Apogee Therapeutics, Inc. | $134.28 | +0.01% | 558K | $8.31B |
| IMVT | NASDAQ | Immunovant, Inc. | $39.84 | -1.04% | 727K | $8.09B |
| HQY | NASDAQ | HealthEquity, Inc. | $99.22 | +1.59% | 974K | $7.91B |
| PCVX | NASDAQ | Vaxcyte, Inc. | $55.99 | -0.39% | 1.1M | $7.89B |
| LQDA | NASDAQ | Liquidia Corporation | $77.08 | -3.58% | 1.6M | $7.67B |
| TEM | NASDAQ | Tempus AI, Inc. | $42.69 | -7.22% | 5.8M | $7.47B |
| RGEN | NASDAQ | Repligen Corporation | $131.96 | -4.10% | 1.4M | $7.44B |
| IBRX | NASDAQ | ImmunityBio, Inc. | $7.10 | -4.05% | 8.5M | $7.44B |
| RYTM | NASDAQ | Rhythm Pharmaceuticals, Inc. | $104.60 | -1.88% | 467K | $7B |
| MIRM | NASDAQ | Mirum Pharmaceuticals, Inc. | $116.62 | -1.88% | 517K | $6.89B |
| LNTH | NASDAQ | Lantheus Holdings, Inc. | $104.82 | +1.05% | 474K | $6.82B |
| COGT | NASDAQ | Cogent Biosciences, Inc. | $39.76 | -1.19% | 1.6M | $6.79B |
| ERAS | NASDAQ | Erasca, Inc. | $19.11 | -1.19% | 3.2M | $6.63B |
| GRFS | NASDAQ | Grifols, S.A. | $7.27 | -0.27% | 3.1M | $6.41B |
| PTCT | NASDAQ | PTC Therapeutics, Inc. | $76.82 | -2.08% | 838K | $6.37B |
| XENE | NASDAQ | Xenon Pharmaceuticals Inc. | $66.04 | -3.25% | 530K | $6.32B |
| BLTE | NASDAQ | Belite Bio, Inc | $152.84 | +1.84% | 172K | $6.15B |
| CGON | NASDAQ | CG Oncology Inc. | $70.19 | -2.31% | 369K | $6.11B |
| LGND | NASDAQ | Ligand Pharmaceuticals Incorporated | $300.53 | -0.54% | 277K | $6.02B |
| TXG | NASDAQ | 10x Genomics, Inc. | $43.22 | -1.19% | 2.7M | $5.87B |
| BLLN | NASDAQ | BillionToOne, Inc. | $126.77 | -0.94% | 479K | $5.8B |
| AMRX | NASDAQ | Amneal Pharmaceuticals, Inc. | $17.50 | -1.96% | 1.2M | $5.72B |
| SRRK | NASDAQ | Scholar Rock Holding Corporation | $47.67 | -3.66% | 839K | $5.71B |
| TWST | NASDAQ | Twist Bioscience Corporation | $87.45 | -6.82% | 1M | $5.62B |
| TVTX | NASDAQ | Travere Therapeutics, Inc. | $57.36 | +1.20% | 1.2M | $5.33B |
| INDV | NASDAQ | Indivior Pharmaceuticals Inc | $39.12 | -3.50% | 838K | $5.06B |
| SHC | NASDAQ | Sotera Health Company | $17.75 | -2.85% | 2.4M | $4.95B |
| RDNT | NASDAQ | RadNet, Inc. | $60.68 | -2.43% | 605K | $4.84B |
| MMED | NASDAQ | MiniMed Group, Inc. Common Stock | $16.92 | -0.06% | 1.1M | $4.73B |
| KNSA | NASDAQ | Kiniksa Pharmaceuticals International, plc | $62.58 | -2.14% | 620K | $4.72B |
| DFTX | NASDAQ | Definium Therapeutics, Inc. | $42.80 | -3.36% | 6K | $4.71B |
| VCYT | NASDAQ | Veracyte, Inc. | $57.26 | -3.16% | 590K | $4.52B |
| CRSP | NASDAQ | CRISPR Therapeutics AG | $47.53 | +0.61% | 1.4M | $4.49B |
| MMSI | NASDAQ | Merit Medical Systems, Inc. | $74.32 | +1.66% | 655K | $4.43B |
| EWTX | NASDAQ | Edgewise Therapeutics, Inc. | $39.58 | +1.98% | 1M | $4.39B |
| CAI | NASDAQ | Caris Life Sciences, Inc. | $15.52 | -0.83% | 4.9M | $4.39B |